Clinical Trials Logo

Carcinosarcomas Uterine clinical trials

View clinical trials related to Carcinosarcomas Uterine.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02993705 Completed - Clinical trials for Carcinosarcoma, Ovarian

Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)

MITO 26
Start date: February 22, 2017
Phase: Phase 2
Study type: Interventional

Multicenter phase II study on trabectedin in patients advanced uterine and ovarian carcinosarcoma. Patients will receive trabectedin until disease progression or unacceptable toxicity. Disease response evaluation will be assessed every 9 weeks.